Integrated Diagnostics Holdings (GB:IDHC) has released an update.
Integrated Diagnostics Holdings has reported a substantial 33% increase in revenues in the first half of 2024, reaching EGP 2,498 million, driven by higher test volumes and increased revenues per test. The company’s profitability has also seen significant improvement, with a 45% rise in EBITDA and a remarkable 127% growth in net profit, resulting in an expanded net profit margin of 19%. This financial growth underscores the company’s successful cost optimization strategies and resilience in the face of economic challenges.
For further insights into GB:IDHC stock, check out TipRanks’ Stock Analysis page.
